U.S. Semiconductors Stock News

Curious whether Johnson Controls International at around US$131 per share still offers value, or if most of the opportunity is already reflected in the price. The stock has posted a 7.3% return year to date, with a 1.2% move over the last week, a 9.0% decline over the past month, and longer term returns of 67.0% over 1 year, 131.1% over 3 years, and 142.6% over 5 years. Recent headlines around large scale energy efficiency projects, smart building solutions, and broader attention on...

Why the PharmaCann settlement matters for IIPR Innovative Industrial Properties (IIPR) has drawn attention after reaching a settlement with PharmaCann to resolve rent default lawsuits, terminate three property leases, and regain possession of facilities in New York, Ohio, and Pennsylvania. See our latest analysis for Innovative Industrial Properties. The PharmaCann settlement lands at a time when momentum in IIPR’s share price is soft in the short term, with a 30 day share price return...

Worthington Enterprises (WOR) has put fresh numbers on the table, with third quarter fiscal 2026 results showing higher sales, earnings and earnings per share, supported by acquisitions and data center related demand. See our latest analysis for Worthington Enterprises. The latest earnings update, buyback progress and ongoing dividends come against a mixed share price backdrop, with a 7 day share price return of 6.42% contrasting with a 30 day share price decline of 9.48%, while the 3 year...

If you are wondering whether BlackRock's current share price reflects its true value, you are not alone. This article focuses exactly on that question. The stock last closed at US$933.85, with returns of 0.7% over 1 year, 49.8% over 3 years, and 37.2% over 5 years, while the year to date return sits at a 13.9% decline and the past month shows a 12.2% decline. Recent coverage has centered on BlackRock's role as a major global asset manager, its influence across exchange traded funds, and its...

If you are wondering whether Flowserve's current share price still offers value, it helps to look past the headline moves and focus on what the underlying numbers are saying about the stock. The share price recently closed at US$72.15, with returns of 1.1% over 7 days, a 18.5% decline over 30 days, 2.0% year to date, 50.0% over 1 year, 123.1% over 3 years, and 102.4% over 5 years. This gives a mixed picture of shorter term swings versus longer term performance. Recent coverage around...

Genpact stock moves: recent performance snapshot Genpact (G) has drawn investor attention after a period of weaker share performance, with the stock showing a 2.2% decline over the past day and deeper losses over the past month and past 3 months. See our latest analysis for Genpact. At a share price of US$36.58, Genpact’s recent 7 day and 30 day share price returns of 5.48% and 7.91% declines, alongside a 1 year total shareholder return of 25.62% decline, suggest momentum has been fading as...

If you are asking whether Amprius Technologies at US$16.12 is still attractively priced or already running ahead of itself, the next sections walk through the key numbers you need to weigh that up. The stock has been volatile recently, with an 11.4% decline over the past 7 days, a 50.2% gain over 30 days, an 84.4% return year to date and a very large 1 year return of 473.7%. Recent coverage has focused on Amprius as a high growth, high volatility name in the Electrical industry, and those...

In March 2026, Ligand Pharmaceuticals expanded its leadership team by appointing healthcare investors Peter Renehan, MD, and Lee Brown as Vice Presidents of Investments and Business Development, while broadening Lauren Hay’s role to Vice President of Portfolio Strategy and Investments to focus on royalty financing and portfolio optimization. Around the same time, Chief Financial Officer Octavio Espinoza sold 3,057 shares for about US$688,000 under a prearranged 10b5-1 plan, alongside company...

Recent share performance and business context MongoDB (MDB) has drawn investor attention after a period of weaker share performance, with the stock showing negative returns over the past week, month and past 3 months, alongside a negative year to date move. This share price backdrop sits against annual revenue of US$2.46b and a reported net loss of US$71.15m, raising questions about how investors should weigh growth in its database platform against profitability and valuation today. See our...

Dollar General announced in March 2026 that Jerry “JJ” Fleeman Jr., a veteran Ahold Delhaize USA executive, will succeed Todd Vasos as CEO and join the Board on January 1, 2027, with Vasos remaining as a Senior Advisor through April 2, 2027 and continuing as a director thereafter. This leadership transition brings deep grocery and digital expertise into a business already reshaped under Vasos by DG Fresh, pOpshelf, international expansion, and enhanced delivery and loyalty programs. Next,...

Wondering if Huntington Ingalls Industries at around US$381.79 is still offering value after a strong run, or if the easy gains are already behind it. The stock has seen a 6.4% decline over the past 7 days and a 14.1% decline over the past 30 days, while the 1 year return stands at 89.4% and the 3 year and 5 year returns are 96.7% and 108.6% respectively. Recent attention on the company has centered on its role in U.S. defense and shipbuilding programs. This often keeps investors focused on...

Commerce Bancshares stock snapshot after recent performance Commerce Bancshares (CBSH) shares recently closed at US$48.07, with the stock showing a 1 day return of 1.88% and a past month decline of 5.73%, extending to 8.75% over the past 3 months. See our latest analysis for Commerce Bancshares. Stepping back, the recent softness in the 1 month share price return of 5.73% and 3 month share price return of 8.75% sits alongside a 1 year total shareholder return of 16.49%. This may indicate...

Norwegian Cruise Line Holdings (NYSE:NCLH) has entered a cooperation agreement with Elliott Investment Management. The company is appointing five new directors to the board, including leaders from travel, finance, and investment sectors. CEO John Chidsey is also becoming Board Chairman as part of the governance changes. Norwegian Cruise Line Holdings runs a global cruise operation, competing with other large operators for leisure travel demand. The cruise sector has been influenced by...

Why Bitdeer’s latest moves matter for BTDR stock Bitdeer Technologies Group (BTDR) has put fresh attention on its stock with two developments: a new SEALMINER DL1 Air Scrypt mining machine and unaudited February 2026 operating metrics showing expanded hash rate and mining activity. See our latest analysis for Bitdeer Technologies Group. The latest product launch and operating update come after a mixed year for investors. The share price is US$8.37, with a 1 month share price return of 8.7%,...

PHINIA stock at a glance PHINIA (PHIN) is catching investor attention after recent share price swings, with a last close at $67.11 and returns ranging from a 7% gain over the past week to a 7.6% decline over the month. See our latest analysis for PHINIA. Recent moves have been choppy, with a 7% 7 day share price return following a 7.6% 30 day share price decline. At the same time, the 1 year total shareholder return of 58.9% points to momentum that has been strong over a longer stretch. If...

What Semtech’s Recent Share Performance Tells You Semtech (SMTC) has drawn investor attention after a recent pullback, with the share price down 2.7% over the past day and about 20% over the past month, despite strong longer term returns. See our latest analysis for Semtech. The recent 30 day share price return of a 20% decline, alongside a 4.1% year to date share price decline, contrasts with a 1 year total shareholder return of 105.9%. This suggests that momentum has cooled after a strong...

GLOBALFOUNDRIES (GFS) has moved into the spotlight after filing multiple U.S. patent infringement lawsuits against Tower Semiconductor, a legal step that puts its manufacturing know how and intellectual property protections front and center for investors. See our latest analysis for GLOBALFOUNDRIES. The legal action lands at a time when the share price is US$42.94, with a 19.78% 90 day share price return and a 16.40% 1 year total shareholder return, contrasting with a 3 year total shareholder...

For investors wondering if CACI International at around US$563 per share still offers value after a strong run, this article explains what the current price may be implying about the stock. The share price is US$563.67 after a 7% decline over the last week and a 7.6% decline over the last month. Despite this, the 1 year return is 51%, and the 3 year and 5 year returns are 90.2% and 126.7% respectively. Recent coverage has focused on the stock's strong multi year performance and the pullback...

If you are wondering whether Vera Therapeutics at around US$38.86 is priced purely on its story or still leaves some value on the table, this article walks through what the current share price actually implies. The stock has had a mixed run, with a 4.1% decline over the past week and a 4.7% decline over the past month, yet it still shows a 45.9% return over the last year and a very large return over three years. Recent attention on Vera Therapeutics has focused on its position in the biotech...

WeRide, listed as NasdaqGM:WRD, has launched a share repurchase program covering up to 10% of its issued share capital. In addition, the buyback follows the company’s recent entry into Slovakia to roll out what it calls the country’s first autonomous vehicle initiative. WeRide also presented its next generation Robotaxi at NVIDIA GTC 2026, highlighting its technical partnership and product roadmap. For anyone tracking autonomous driving, WeRide sits at the intersection of software, hardware...

If you are wondering whether Crane NXT is attractively priced or just a value trap, starting with a clear view of its recent share performance and fundamentals can help frame the question. The stock last closed at US$41.15, with a 1.9% gain over the past week, a 14.8% decline over the past month, a 13.8% decline year to date, and a 18.8% decline over the last year. Its 3 year return sits at 9.4%. Recent coverage has focused on providing evergreen context for Crane NXT, aiming to keep...

Wondering whether AllianceBernstein Holding at around US$35.66 is priced attractively, too expensive, or somewhere in between? This article walks through the key signals that matter for you as a shareholder or potential investor. The stock has seen mixed returns, with a 3.9% decline over the past week, a 9.2% decline over the last 30 days, a 7.7% decline year to date, but a 1.0% return over 1 year and gains of 26.7% over 3 years and 31.8% over 5 years. These moves have come as investors...

Wondering whether Southern Copper at around US$162 a share still makes sense for your portfolio, or if the easy gains are already behind it. The stock has returned 6.1% over the last 7 days, while the 30 day return sits at a 25.8% decline and the 1 year return stands at 83.6%, with longer 3 and 5 year returns of 149.7% and 208.1%. Recent market attention has focused on Southern Copper as part of a broader interest in large copper producers and their role in supply for global industry. That...

Why the brepocitinib data matters for Roivant Sciences (ROIV) The Phase 3 VALOR trial results for brepocitinib in dermatomyositis, published in the New England Journal of Medicine and paired with an FDA Priority Review, put a key Roivant Sciences (ROIV) asset firmly in focus for investors. See our latest analysis for Roivant Sciences. Roivant’s recent brepocitinib milestones arrive after a 1 year total shareholder return of 155.49% and a 3 year total shareholder return of 259.35%. The share...